These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24698975)

  • 1. SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury.
    Ferrandi M; Molinari I; Matafora V; Zerbini G; Trevisani F; Rastaldi MP; Simonini M; Giardino L; Ferrari P; Manunta P
    Hum Mol Genet; 2014 Aug; 23(16):4371-82. PubMed ID: 24698975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
    Ferrandi M; Molinari I; Rastaldi MP; Ferrari P; Bianchi G; Manunta P
    J Pharmacol Exp Ther; 2014 Nov; 351(2):278-87. PubMed ID: 25187430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin.
    Stenström K; Takemori H; Bianchi G; Katz AI; Bertorello AM
    J Hypertens; 2009 Dec; 27(12):2452-7. PubMed ID: 19657284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.
    Ferrandi M; Cusi D; Molinari I; Del Vecchio L; Barlassina C; Rastaldi MP; Schena FP; Macciardi F; Marcantoni C; Roccatello D; Peters LL; Armelloni S; Min L; Giardino L; Mattinzoli D; Camisasca C; Palazzo F; Manunta P; Ferrari P; Bianchi G
    J Mol Med (Berl); 2010 Feb; 88(2):203-17. PubMed ID: 19838659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies.
    Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G
    Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt-inducible kinase 1 influences Na(+),K(+)-ATPase activity in vascular smooth muscle cells and associates with variations in blood pressure.
    Popov S; Silveira A; Wågsäter D; Takemori H; Oguro R; Matsumoto S; Sugimoto K; Kamide K; Hirose T; Satoh M; Metoki H; Kikuya M; Ohkubo T; Katsuya T; Rakugi H; Imai Y; Sanchez F; Leosdottir M; Syvänen AC; Hamsten A; Melander O; Bertorello AM
    J Hypertens; 2011 Dec; 29(12):2395-403. PubMed ID: 22045124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium.
    Efendiev R; Krmar RT; Ogimoto G; Zwiller J; Tripodi G; Katz AI; Bianchi G; Pedemonte CH; Bertorello AM
    Circ Res; 2004 Nov; 95(11):1100-8. PubMed ID: 15528469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
    Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury.
    Ferrandi M; Molinari I; Matafora V; Zerbini G; Trevisani F; Rastaldi MP; Simonini M; Giardino L; Ferrari P; Manunta P
    Hum Mol Genet; 2017 Feb; 26(3):660. PubMed ID: 25392177
    [No Abstract]   [Full Text] [Related]  

  • 11. Ouabain antagonists as antihypertensive agents.
    Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P
    Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OS062. Oxidative stress mediates podocyte injury in preeclampsia.
    Zhao S; Gu Y; Groome L; Wang Y
    Pregnancy Hypertens; 2012 Jul; 2(3):210-1. PubMed ID: 26105276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.
    Ferrari P; Ferrandi M; Valentini G; Bianchi G
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R529-35. PubMed ID: 16467500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury.
    Villa L; Buono R; Ferrandi M; Molinari I; Benigni F; Bettiga A; Colciago G; Ikehata M; Messaggio E; Rastaldi MP; Montorsi F; Salonia A; Manunta P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
    Manunta P; Maillard M; Tantardini C; Simonini M; Lanzani C; Citterio L; Stella P; Casamassima N; Burnier M; Hamlyn JM; Bianchi G
    J Hypertens; 2008 May; 26(5):914-20. PubMed ID: 18398333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'.
    Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G
    Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adducin and hypertension.
    Staessen JA; Bianchi G
    Pharmacogenomics; 2005 Oct; 6(7):665-9. PubMed ID: 16207143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.
    Liu Y; Liang W; Yang Y; Pan Y; Yang Q; Chen X; Singhal PC; Ding G
    Cell Signal; 2015 Apr; 27(4):867-77. PubMed ID: 25652011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury.
    Wang L; Fields TA; Pazmino K; Dai Q; Burchette JL; Howell DN; Coffman TM; Spurney RF
    J Am Soc Nephrol; 2005 Dec; 16(12):3611-22. PubMed ID: 16267159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.